Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-024264

Pres. & Chief Exec. Officer sold 9,836 shares at $25.03 ($246,195)

  • Pres. & Chief Exec. Officer acquired 6,214 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Option exercise 10b5-1 +6,214 $2.39 $14,851 27,693 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −6,214 $25.03 $155,536 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −1,357 $25.03 $33,966 48,852 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −1,153 $25.03 $28,860 41,520 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −278 $25.03 $6,958 2,780 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −278 $25.03 $6,958 2,780 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −278 $25.03 $6,958 2,780 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Sale 10b5-1 −278 $25.03 $6,958 2,780 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-04-06 Option exercise · Stock option (right to buy) 10b5-1 −6,214 7,518 D
Open-market sales · 9,836 sh · avg $25.03 · $246,195
Loading xslF345X06/wk-form4_1775680461.xml…